Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 10, 2016 - Issue
Submit an article Journal homepage
514
Views
46
CrossRef citations to date
0
Altmetric
Original Research

Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials

Narong Maneeton1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandCorrespondence[email protected]
,
Benchalak Maneeton1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
,
Pakapan Woottiluk2 Psychiatric Nursing Division, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand
,
Surinporn Likhitsathian1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
,
Sirijit Suttajit1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
,
Vudhichai Boonyanaruthee1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
&
Manit Srisurapanont1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
 show all
Pages 259-276 | Published online: 12 Jan 2016

Citations (46)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lu Han, Jia-Qin Gu, Jue-Hui Mao, Xiao-Qin Liu & Zheng Jiao. (2023) Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review. Expert Review of Clinical Pharmacology 0:0, pages 1-16.
Read now
Benchalak Maneeton, Suwannee Putthisri, Narong Maneeton, Pakapan Woottiluk, Sirijit Suttajit, Chawanun Charnsil & Manit Srisurapanont. (2017) Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis. Neuropsychiatric Disease and Treatment 13, pages 1023-1032.
Read now
Massimiliano Buoli, Alice Caldiroli & Marta Serati. (2017) Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 351-359.
Read now
Jan Prasko, Ales Grambal, Petra Kasalova, Dana Kamardova, Marie Ociskova, Michaela Holubova, Kristyna Vrbova, Zuzana Sigmundova, Klara Latalova, Milos Slepecky & Marta Zatkova. (2016) Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders. Neuropsychiatric Disease and Treatment 12, pages 2659-2676.
Read now

Articles from other publishers (42)

Xue-Zhu Feng, Zhe Li, Zi-Yi Li, Ke Wang, Xuan Tan, Yu-Yu Zhao, Wei-Feng Mi, Wei-Li Zhu, Yan-Ping Bao, Lin Lu & Su-Xia Li. (2024) Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis. Psychiatry Research 332, pages 115637.
Crossref
Leonardo Caixeta, Ciro Mendes Vargas, Yanley Lucio, Leonardo Baldaçara, Suzy Mara Maia dos Reis Alfaia, Arthur Rabahi & Victor de Melo Caixeta. (2023) A quetiapina: 3 medicamentos em uma única molécula: uma breve revisão e atualização. Debates em Psiquiatria 13, pages 1-20.
Crossref
Andrew D. Krystal. (2023) Insomnia medications: History, characteristics, and guidelines for optimal use in clinical practice. Journal of Sleep Research 32:6.
Crossref
Aysha Mendes. (2023) Evolution of the use of quetiapine. Journal of Prescribing Practice 5:11, pages 452-453.
Crossref
Yifan Wang, Xiaofeng Chen, Wei Wei, Yiyun Ding, Rongjuan Guo, Jia Xing & Jialin Wang. (2023) Efficacy and safety of the Chinese herbal medicine Xiao Yao San for treating anxiety: a systematic review with meta-analysis and trial sequential analysis. Frontiers in Pharmacology 14.
Crossref
Ju. E. Azimova, Yu. P. Sivolap & K. A. Ishchenko. (2023) Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder. Neurology, Neuropsychiatry, Psychosomatics 15:3, pages 68-75.
Crossref
Jolanta Jaśkowska, Anna Karolina Drabczyk, Damian Kułaga, Przemysław Zaręba, Zbigniew Majka & Przemysław Jodłowski. (2023) A new synthetic ultrasound-assisted method for dibenzoepines. Heliyon 9:7, pages e18319.
Crossref
Radomir Juza, Kamil Musilek, Eva Mezeiova, Ondrej Soukup & Jan Korabecny. (2022) Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders . Medicinal Research Reviews 43:1, pages 55-211.
Crossref
Dennis E. CurryBrooke L. Richards. (2022) A Brief Review of Quetiapine. American Journal of Psychiatry Residents' Journal 18:2, pages 20-22.
Crossref
Eliška Bartečková, Jana Hořínková & Pavel Křenek. (2022) Mixed anxiety and depressive disorder: a review of the literature. Psychiatrie pro praxi 23:3, pages 153-159.
Crossref
Amir Garakani, Rafael C. Freire, Frank D. Buono, Robyn P. Thom, Kaitlyn Larkin, Melissa C. Funaro, Mona Salehi & Mercedes M. Perez-Rodriguez. (2022) An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol. PLOS ONE 17:6, pages e0269772.
Crossref
Falk Leichsenring, Christiane Steinert, Sven Rabung & John P.A. Ioannidis. (2022) The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses. World Psychiatry 21:1, pages 133-145.
Crossref
Mark J. Millan. (2022) Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action. Therapeutic Advances in Psychopharmacology 12, pages 204512532211051.
Crossref
Amanda Silva de Miranda, Rodrigo Novaes Ferreira, Antônio Lúcio Teixeira & Aline Silva de Miranda. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1583 1605 .
Sang Ah Lee, Suk Ju Cho & Jae Cheol Moon. (2021) The Effect of Atypical Anti-psychotic Agents on Obesity and Glucose Metabolism. Journal of Medicine and Life Science 18:3, pages 49-55.
Crossref
Dan J. Stein. (2021) Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine. Advances in Therapy 38:S2, pages 52-60.
Crossref
Andrew J. Melaragno. (2021) Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance. FOCUS 19:2, pages 145-160.
Crossref
Brenda WJH Penninx, Daniel S Pine, Emily A Holmes & Andreas Reif. (2021) Anxiety disorders. The Lancet 397:10277, pages 914-927.
Crossref
Yusuf S. Althobaiti. (2021) Quetiapine-Induced Place Preference in Mice: Possible Dopaminergic Pathway. Pharmaceuticals 14:2, pages 156.
Crossref
Wenqiang Kong, Huiyuan Deng, Jie Wan, Yilu Zhou, Yan Zhou, Bihui Song & Xiuling Wang. (2020) Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials. Frontiers in Pharmacology 11.
Crossref
Eliška Nosková, Antonín Šebela & Pavla Stopková. (2020) Current trends in treatment of generalised anxiety disorder. Psychiatrie pro praxi 21:2, pages 66-72.
Crossref
Simon J. C. Davies. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology 543 576 .
Robert McCutcheon, Stephen J. Kaar & Oliver D. Howes. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology 290 325 .
David S. Baldwin & Nathan T. M. Huneke. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology 268 289 .
Lina Fine. (2020) Pharmacologic Approach to Insomnia. Physical Medicine and Rehabilitation Clinics of North America 31:2, pages 255-264.
Crossref
Yu.P. Sivolap. (2020) Systematics and treatment of anxiety disorders. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:7, pages 121.
Crossref
Yu.P. Sivolap & Y.E. Azimova. (2020) Anxiety in neurological practice. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:5, pages 165.
Crossref
Amanda Silva de Miranda, Rodrigo Novaes Ferreira, Antônio Lúcio Teixeira & Aline Silva de Miranda. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 23 .
Jens Plag & Jürgen Hoyer. (2019) Die generalisierte Angststörung – ein Update. PSYCH up2date 13:03, pages 243-260.
Crossref
April Slee, Irwin Nazareth, Paulina Bondaronek, Yifeng Liu, Zhihang Cheng & Nick Freemantle. (2019) Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. The Lancet 393:10173, pages 768-777.
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 119 .
Jörg Angenendt, Ulrich Frommberger, Mathias Berger & Katharina Domschke. 2019. Psychische Erkrankungen. Psychische Erkrankungen 445 481.e3 .
Katie R. Thorsness, Corey Watson & Elizabeth M. LaRusso. (2018) Perinatal anxiety: approach to diagnosis and management in the obstetric setting. American Journal of Obstetrics and Gynecology 219:4, pages 326-345.
Crossref
Andreas Ströhle, Jochen Gensichen & Katharina Domschke. (2018) The Diagnosis and Treatment of Anxiety Disorders. Deutsches Ärzteblatt international.
Crossref
G. Fond, N. Resseguier, F. Schürhoff, O. Godin, M. Andrianarisoa, L. Brunel, E. Bulzacka, B. Aouizerate, F. Berna, D. Capdevielle, I. Chereau, T. D’Amato, C. Dubertret, J. Dubreucq, C. Faget, F. Gabayet, C. Lançon, P. M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, A. Schandrin, M. Urbach, P. Vidailhet, L. Boyer & M. Leboyer. (2017) Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort. European Archives of Psychiatry and Clinical Neuroscience 268:6, pages 541-553.
Crossref
Guillaume Fond, Christophe Lançon, Pascal Auquier & Laurent Boyer. (2018) C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review. Frontiers in Psychiatry 9.
Crossref
Eliška Nosková, Pavla Stopková & Antonín Šebela. (2017) Current trends in treatment of anxiety disorders. Psychiatrie pro praxi 18:3, pages 106-113.
Crossref
Baptiste Pignon, Chloé Tezenas du Montcel, Louise Carton & Antoine Pelissolo. (2017) The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. Current Psychiatry Reports 19:12.
Crossref
J. Diemer, P. Zwanzger, I. Fohrbeck, M. Zavorotnyy, S. Notzon, K. Silling, V. Arolt, K. Domschke & B. Pfleiderer. (2017) Influence of single-dose quetiapine on fear network activity – A pharmaco-imaging study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 76, pages 80-87.
Crossref
Nicholas Zareifopoulos & Irene Dylja. (2017) Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis. Asian Journal of Psychiatry 26, pages 115-122.
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 111 .
Ion-George Anghelescu. (2016) Darauf müssen Sie achten, wenn die offizielle Indikation fehlt. DNP - Der Neurologe und Psychiater 17:4, pages 34-38.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.